Biotech / Pharma
Merida Biosciences
Biotech / Pharma
Eli Lilly agrees to acquire Merida Biosciences for up to $2.875 billion. The acquisition is part of Eli Lilly's acquisition spree driven by GLP-1 revenue.
Founded
Region
Investors
People